ストックスクリーナーアプリを入手
21.41
0.47%
0.10
Oculis Holding Ag (OCS) 最新ニュース
(OCS) On The My Stocks Page - Stock Traders Daily
Oculis Holding AG (NASDAQ:OCS) Short Interest Down 68.6% in January - MarketBeat
Oculis (NASDAQ:OCS) Shares Down 7.2%Should You Sell? - MarketBeat
Oculis Holding AG Prices $100 Million Oversubscribed Share Offering - TipRanks
Oculis Holding Prices Offering of 5 Million Shares -February 14, 2025 at 04:36 am EST - Marketscreener.com
Biopharmaceutical Company Oculis Seeks $100 Million from Share Sale -February 14, 2025 at 12:56 am EST - Marketscreener.com
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares - The Manila Times
Major Funding Breakthrough: Oculis Secures $100M for Revolutionary Eye Treatment Development - StockTitan
Oculis Raises Massive $100M War Chest: Major Pipeline Expansion for Revolutionary Eye Treatment - StockTitan
Oculis greinir frá umframeftirspurn og öðrum niðurstöðum 100 milljón USD útboðs á almennum hlutum - GlobeNewswire Inc.
Institutions along with retail investors who hold considerable shares inOculis Holding AG (NASDAQ:OCS) come under pressure; lose 8.9% of holdings value - Simply Wall St
(OCS) Trading Report - Stock Traders Daily
abrdn plc Buys 188,871 Shares of Oculis Holding AG (NASDAQ:OCS) - MarketBeat
Oculis (NASDAQ:OCS) Trading Down 0.2%Time to Sell? - MarketBeat
Insider Alert: Oculis Leadership Team Hits Major Share Vesting Milestone - StockTitan
Oculis (NASDAQ:OCS) Shares Down 0.2% – Time to Sell? - Defense World
Oculis updates share capital for its existing at-the-market offering program - The Manila Times
Oculis Secures Financial Flexibility: Strategic $100M ATM Program Backed by 2.5M Fresh Shares - StockTitan
Here's Why Momentum in Oculis Holding AG (OCS) Should Keep going - MSN
Trend Tracker for (OCS) - Stock Traders Daily
Oculis Announces Significant Voting Rights Changes Following Íslandsbanki Activity - StockTitan
Oculis Is An Interesting Growth Bet On Non-Invasive Eye Care (NASDAQ:OCS) - Seeking Alpha
Oculis Announces Major Voting Rights Changes Involving Íslandsbanki in Switzerland - StockTitan
(OCS) Proactive Strategies - Stock Traders Daily
Here's What Could Help Oculis Holding AG (OCS) Maintain Its Recent Price Strength - MSN
Oculis (NASDAQ:OCS) Reaches New 12-Month HighTime to Buy? - MarketBeat
Oculis (NASDAQ:OCS) Shares Gap Up – Here’s Why - Defense World
Head to Head Comparison: Oculis (NASDAQ:OCS) vs. Immunome (NASDAQ:IMNM) - Defense World
Accure Therapeutics partner Oculis reached positive phase 2 results for lead neuroprotective therapy - MENAFN.COM
Oculis (NASDAQ:OCS) Shares Gap UpWhat's Next? - MarketBeat
Trading (OCS) With Integrated Risk Controls - Stock Traders Daily
Chardan Capital Reiterates Buy Rating for Oculis (NASDAQ:OCS) - Defense World
Oculis (NASDAQ:OCS) Sees Large Volume IncreaseHere's Why - MarketBeat
HC Wainwright Reaffirms “Buy” Rating for Oculis (NASDAQ:OCS) - Defense World
Oculis' (OCS) "Buy" Rating Reiterated at Chardan Capital - MarketBeat
Oculis reiterates shares target, buy rating post-trial - Investing.com
Stifel maintains Oculis stock Buy rating, $35 target post-study - Investing.com India
Oculis Trial Shows Potential for Optical Neuroprotective Therapy - Yahoo Finance
Oculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis - TipRanks
Stifel maintains Oculis stock Buy rating, $35 target post-study By Investing.com - Investing.com South Africa
Oculis' (OCS) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Oculis presents 'groundbreaking' data in optic neuritis with OCS-05 - BioWorld Online
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):